Target intelligence / Profile preview

Eschar proteins

Molecular classification
Other
01

Overview

Eschar proteins are the primary structural and biological components of an eschar, which is the necrotic, devitalized tissue that forms over wounds, particularly in severe burns and chronic ulcers [1, 6]. These proteins predominantly include fibrous proteins such as collagen, fibrin, and elastin, as well as other components like fibronectin and hemoglobin, which often become denatured or cross-linked within the necrotic matrix [1, 17]. In clinical practice, eschar proteins serve as the therapeutic target for enzymatic debridement agents, which aim to liquefy and remove the necrotic tissue to facilitate wound healing and prevent infection [6, 24]. Drugs such as collagenase, bromelain-derived enzymes, and various microbial proteases interact with these proteins by catalyzing their breakdown, thereby cleaning the wound bed and allowing for subsequent tissue regeneration or grafting [19, 23]. Notable safety concerns include the potential for proteolytic damage to healthy surrounding tissue and localized pain or irritation during the debridement process [16, 24].

Other names
Necrotic tissue proteinsWound eschar proteinsSlough proteins
02

Mechanism of action

Enzymatic proteolysis and digestion of necrotic tissue proteins to facilitate debridement and wound healing.

03

Biological functions

Other
04

Disease associations

OtherInfection
05

Safety considerations

Damage to healthy tissuePainBleedingAllergic reactionsIncomplete debridement
06

Interacting drugs

Collagenase clostridium histolyticum

6 more in the full profile.

07

Biomarkers

Eschar thicknessWound bed appearanceFibrin levelsCollagen denaturation state

Beyond the preview

Go deeper on Eschar proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eschar proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call